It is not surprising that students at UNC-Chapel Hill are protesting a proposal to raise tuition 40 percent in the next five years. More people ought to be protesting with them.
What is difficult to understand is why one member of the UNC Board of Governors is so upset by the plan and the deep budget cuts to the university made by the General Assembly that have prompted it.
Fred Eshelman, the CEO of Pharmaceutical Product Development, Inc. in Wilmington who was elected to the board this year by the Republicans in the General Assembly, says the board should refuse to raise tuition and force state lawmakers to make up the difference.
For the complete article, please pick up a copy of The Daily Reflector. Current home delivery and electronic edition subscribers may log in to access this article at no charge. To become a subscriber, please click here or contact Customer Service at (252) 329-9505.